Patent ID: 11903950
Assignee: NEWAVE PHARMACEUTICAL INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 7:
8. The compound according to claim 7, or the N-oxide thereof, or the pharmaceutically acceptable salt, solvate, polymorph, tautomer, stereoisomer, or isotopic form thereof, wherein, , in which each Za and Zb is independently —O—, —CH2—, —N(Ra)—, or —S—; wherein Ra of Za and Zb, independently, is H, D, C1-C6alkyl, C2-C6alkenyl, C1-C6alkylcarbonyl, C1-C6alkoxycarbonyl, C3-C6cycloalkyl, 5-8 membered monocyclic heterocycloalkyl, C6-C14aryl, or 5-8 membered monocyclic heteroaryl, in which said C1-C6alkyl, C3-C6cycloalkyl, 5-8 membered monocyclic heterocycloalkyl, C6-C14aryl, or 5-8 membered heteroaryl of Ra of Za and Zb is optionally substituted with one or more Re.